Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2012-10-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm301099xPMID 22984948PMCID PMC3491656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome.

  2012cited by this paper
• Structure of flavonoids influences the degree inhibition of Benzo(a)pyrene - induced DNA damage and micronuclei in HepG2 cells.

  2011cited by this paper
• The Putative Metal Coordination Motif in the Endonuclease Domain of Human Parvovirus B19 NS1 Is Critical for NS1 Induced S Phase Arrest and DNA Damage

  2011cited by this paper
• Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging

  2011cited by this paper
• L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.

  2011cited by this paper
• Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers

  2011cited by this paper
• A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

  2010cited by this paper
• Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice

  2010cited by this paper
• A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect.

  2010cited by this paper
• TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

  2008cited by this paper
• Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment.

  2007cited by this paper
• The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

  2007cited by this paper
• Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety

  2007cited by this paper
• Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.

  2007cited by this paper
• Adult hippocampal neurogenesis in depression

  2007cited by this paper
• hERG potassium channels and cardiac arrhythmia

  2006cited by this paper
• A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience

  2006cited by this paper
• The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

  2005cited by this paper
• MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm

  2005cited by this paper
• Essential role of brain-derived neurotrophic factor in adult hippocampal function.

  2004cited by this paper
• Forced swimming test in mice: a review of antidepressant activity

  2004cited by this paper
• Subcutaneously administered apomorphine

  2004cited by this paper
• Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects

  2003cited by this paper
• Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

  2003cited by this paper
• Assessing antidepressant activity in rodents: recent developments and future needs.

  2002cited by this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cited by this paper
• Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview.

  1996cited by this paper
• Evaluation of the micronucleus test in vitro using chinese hamster cells: Results of four chemicals weakly positive in the in vivo micronucleus test

  1995cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper

• Research Progress on BDNF and Depression.

  2025cites this paper
• A Combined Computational and Experimental Approach to Studying Tropomyosin Kinase Receptor B Binders for Potential Treatment of Neurodegenerative Diseases

  2024cites this paper
• TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury.

  2023cites this paper
• Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B.

  2022cites this paper
• Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein

  2022cites this paper
• Metabolic protection by the dietary flavonoid 7,8-dihydroxyflavone requires an intact gut microbiome

  2022cites this paper
• Treating Parkinson’s Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase

  2022cites this paper
• Identification of TrkB Binders from Complex Matrices Using a Magnetic Drug Screening Nanoplatform.

  2021cites this paper
• Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases.

  2021cites this paper
• Sex-Dependent Effects of 7,8-Dihydroxyflavone on Metabolic Health Are Associated with Alterations in the Host Gut Microbiome

  2021cites this paper
• 7,8-Dihydroxyflavone Alleviates Anxiety-Like Behavior Induced by Chronic Alcohol Exposure in Mice Involving Tropomyosin-Related Kinase B in the Amygdala

  2020cites this paper
• Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines

  2019cites this paper
• Developing Insulin and BDNF Mimetics for Diabetes Therapy.

  2019cites this paper
• 7,8-Dihydroxyflavone potentiates ongoing epileptiform activity in mice brain slices.

  2019cites this paper
• Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging

  2019cites this paper
• Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

  2018cites this paper
• No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.

  2017cites this paper
• Identification de biomarqueurs génétiques de réponse à la venlafaxine dans une cohorte de patients déprimés

  2017cites this paper
• TrkB Receptor Agonist 7,8-Dihydroxyflavone and Its Therapeutic Potential for Traumatic Brain Injury

  2017cites this paper
• Myelin-induced inhibition in a spiral ganglion organ culture - Approaching a natural environment in vitro.

  2017cites this paper
• Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm.

  2017cites this paper
• Fisetin provides antidepressant effects by activating the tropomyosin receptor kinase B signal pathway in mice

  2017cites this paper
• The role of melatonin, neurokinin, neurotrophic tyrosine kinase and glucocorticoid receptors in antidepressant-like effect

  2017cites this paper
• Regulation of actions and habits by ventral hippocampal trkB and adolescent corticosteroid exposure

  2017cites this paper
• 7,8-Dihydroxyflavone reverses the depressive symptoms in mouse chronic mild stress.

  2016cites this paper
• 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders

  2016cites this paper
• Antidepressant-like effects and mechanisms of flavonoids and related analogues.

  2016cites this paper
• BDNF - a key transducer of antidepressant effects.

  2016cites this paper
• Improvement of the hydrophilicity of 7, 8-dihydroxyflavone by in situ grafting of PEG-A via RAFT polymerization and the drug efficacy tests

  2016cites this paper
• Room‐Temperature Practical Copper‐Catalyzed Amination of Aryl Iodides

  2016cites this paper
• Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

  2015cites this paper
• Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.

  2015cites this paper
• 7, 8-Dihydroxyflavone induces synapse expression of AMPA GluA1 and ameliorates cognitive and spine abnormalities in a mouse model of fragile X syndrome.

  2015cites this paper
• The Effects of 7,8-Dihydroxyflavone (7,8-DHF) on Neuroprotection and Neuroplasticity Follwing a Traumatic Brain Injury

  2015cites this paper
• Die Regulation und Stimulation des Neuritenwachstums im Spiralganglion der Mauscochlea durch neurotrophe Faktoren

  2015cites this paper
• Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

  2015cites this paper
• BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.

  2015cites this paper
• Danggui-Jakyak-San enhances hippocampal long-term potentiation through the ERK/CREB/BDNF cascade.

  2015cites this paper
• Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.

  2015cites this paper
• Les polymorphismes génétiques du TRKB : influence sur l’efficacité des antidépresseurs chez des malades déprimés

  2015cites this paper
• Flavones: an important scaffold for medicinal chemistry.

  2014cites this paper
• Vasorelaxing and antihypertensive effects of 7,8-dihydroxyflavone.

  2014cites this paper
• Biochemical and Biophysical Investigation of the Brain-derived Neurotrophic Factor Mimetic 7,8-Dihydroxyflavone in the Binding and Activation of the TrkB Receptor*

  2014cites this paper
• Evaluation of presynaptic dopamine dynamics after: Toluene inhalation or TrkB receptor activation

  2014cites this paper
• Neuroprotection in demyelinating diseases: The therapeutic potential of the neurotrophins

  2014cites this paper
• Chapter Five - Stimulating Neurotrophin Receptors in the Treatment of Neurodegenerative Disorders

  2014cites this paper
• Développement et radiosynthèse de ligands du récepteur tyrosine kinase neurotrophique type 2 (TrkB) marqués aux carbone-11 et fluor-18 pour l’imagerie cérébrale par tomographie d’émission de positons

  2014cites this paper
• Neurotrophe Naturstoffe – ihre Chemie und Biologie

  2014cites this paper
• A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

  2014cites this paper
• Neurotrophic natural products: chemistry and biology.

  2014cites this paper
• BDNF–TrkB signaling as a therapeutic target in neuropsychiatric disorders

  2014cites this paper
• Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System

  2014influential citation
• Brain-Derived Neurotrophic Factor for Depression Therapeutics

  2014cites this paper
• Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.

  2013cites this paper
• Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease

  2013cites this paper
• Protection of Spiral Ganglion Neurons from Degeneration Using Small-Molecule TrkB Receptor Agonists

  2013cites this paper
• Small molecules activating TrkB receptor for treating a variety of CNS disorders.

  2013cites this paper
• Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics.

  2013cites this paper
• Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves

  2013cites this paper
• Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one.

  2013cites this paper
• Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine.

  2013cites this paper
• Evolving therapeutic targets in ischemic stroke: a concise review.

  2013cites this paper
• VIJISHA K. RAJAN “THEORETICAL INVESTIGATION ON THE RADICAL SCAVENGING ACTIVITY AND SOME OTHER APPLICATIONS OF NATURAL POLYPHENOLS”. THESIS.DEPARTMENT OF CHEMISTRY, UNIVERSITY OF CALICUT, 2018. CHAPTER 6 EVALUATION OF STRUCTURE, RADICAL SCAVENGING, UV FILTER, TOXICOLOGICAL AND PHARMACOKINETIC PROPERT

  year unknowncites this paper